Reply to Comment on Glucagon-like Peptide-1 Receptor Agonist Use and Risk of Cataract Development. Ahuja AS, Paredes AA 3rd, Ahuja SA, Young BK, et al. Am J Ophthalmol 2025 Dec 30:S0002-9394(25)00675.

Read + Share

Amedeo Smart

Independent Medical Education

Ahuja AS, Paredes AA 3rd, Ahuja SA, Young BK, et al. Reply to Comment on Glucagon-like Peptide-1 Receptor Agonist Use and Risk of Cataract Development. Am J Ophthalmol 2025 Dec 30:S0002-9394(25)00675.
PMID: 41478534